4.0 Article

Standardisation of molecular monitoring for chronic myeloid leukaemia

期刊

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.beha.2009.04.001

关键词

BCR-ABL; real time PCR; international scale; minimal residual disease

资金

  1. European LeukemiaNet
  2. UK Department of Health
  3. Novartis through the European Treatment and Outcome Study (EUTOS)
  4. Bristol-Myers Squibb

向作者/读者索取更多资源

Molecular monitoring of chronic myeloid leukaemia (CIVIL) patients by real time quantitative reverse transcriptase PCR (RQ-PCR) is of clinical value, but the use of diverse laboratory protocols and units of measurement make it difficult to compare results between and sometimes within centres. This review explores the intrinsic difficulties in standardising the RQ-PCR analysis, summarises the progress that has been made following the proposal for a new International Scale for BCR-ABL measurement and discusses how further improvements are likely to be made. (C) 2009 Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.0
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据